An explanation of the noncorrespondence between assessment methods of cyclosporin G. M. Randleff-RasmussenM. M. J. OosthuizenJ. A. Myburgh Original Articles Pages: 181 - 186
A retrospective and prospective study of the number of kidney transplants in 31 countries C. ChevalierJ. M. DupuyG. Foulon Original Articles Pages: 187 - 192
Pancreatic autotransplantation in the pig: variations in epigastric arterial blood supply F. A. ZimmermannG. PistoriusI. Marzi Original Articles Pages: 193 - 198
Donor-specific transfusion via the portal venous route induces prolongation of H-2-compatible but not H-2-incompatible cardiac graft survival D. GóreckiM. JakóbisiakJ. Czyźyk Original Articles Pages: 199 - 202
Low-dose cyclosporin A therapy in cadaver renal transplantation in children H. RuderJ. StrehlauK. Schärer Original Articles Pages: 203 - 208
Lymphokine-activated killer (LAK) activity to cultured rat kidney parenchymal components in vitro Y. NietosvaaraR. RenkonenP. Häyry Original Articles Pages: 209 - 213
The increasing importance of chronic rejection as a cause of renal allograft failure M. J. S. DennisM. C. FosterR. W. Blamey Original Articles Pages: 214 - 217
Prevention of reperfusion injury in ischemic-reperfused hearts by oxypurinol and allopurinol L. LoBalsamoJ. BergslandM. J. Feldman Original Articles Pages: 218 - 222
Tubulointerstitial nephritis caused by the antiviral agent foscarnet G. NybergC. SvalanderH. Persson Original Articles Pages: 223 - 227
Fibromuscular dysplasia in donor kidneys — experience with three cases R. LinderH. BillingC. -G. Groth Brief Reports Pages: 228 - 231
Aztreonam can safely be used in combination with cyclosporin without aggravating nephrotoxicity R. C. RietbroekA. J. HoitsmaR. A. P. Koene Brief Reports Pages: 232 - 234